The tweet was deleted by the author.
But we saved everything 🙂.
Zevra Therapeutics will announce its first quarter 2026 financial results and deliver a corporate update on Wednesday, May 6, 2026.
The company has arranged a live webcast event at 4:30 p.m. ET, providing investors with an opportunity to hear the latest performance figures and strategic outlook. Registration details are available in the official release. The event will address Zevra Therapeutics’ advancements and plans within the rare diseases sector.
Earlier this year, Zevra Therapeutics announced participation in AANAM 2026 in Chicago to connect with the neurology community regarding Niemann-Pick disease type C. Additional details were outlined in the company’s event disclosure. The engagements are part of Zevra’s ongoing activities in rare disease therapeutics.